Phase 3 Type 2 Diabetes Trial, Not Yet Recruiting NCT07156500 Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Phase 3 Type 2 Diabetes Trial, Not Yet Recruiting

NCT07156500
Not Yet Recruiting Phase 3

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged 18 or older at the time of signing the consent form, of any gender.
  • People who have been diagnosed with type 2 diabetes for at least 90 days before the screening visit.
  • People who have been managing their diabetes with diet and exercise alone for at least 90 days before the screening visit.
  • People whose HbA1c (a blood sugar measurement taken over time) falls between 7.5% and 10.5% at the screening visit.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with very high blood pressure that is difficult to control — specifically, a top number of 160 or higher, or a bottom number of 100 or higher, at screening, whether or not they are taking blood pressure medication.
  • People who have been diagnosed with, or are suspected of having, type 1 diabetes, or other specific or secondary forms of diabetes.
  • People with a history of significant blood disorders (such as sickle cell disease, a type of anaemia where red blood cells break down too quickly, or certain bone marrow conditions), or conditions that affect the stability or lifespan of red blood cells (such as malaria or an overactive spleen).
  • People with a hormonal condition (such as Cushing's syndrome, or an overactive or underactive thyroid) that may significantly affect body weight — though people with an underactive thyroid may still be considered if their thyroid medication dose has been stable for at least 6 months (confirm with trial site).
  • People who have had a serious infection, a major injury, or a moderate-to-large surgery within the 4 weeks before the screening visit.
  • People who have taken part in a clinical trial of any medicine or medical device within 12 weeks before screening, which includes having signed a consent form and used an experimental treatment or device (including a placebo); or people who are still within 5 half-lives of a previous trial drug at the time of screening, whichever period is longer (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 3
Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Registry
ClinicalTrials.gov
Start date
30 September 2025
Est. completion
30 March 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in HbA1c

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov